Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Paediatric onset study to assess the efficacy of insulin pump therapy using the MiniMed Paradigm REAL-Time system during the first year of diabetes in children and adolescents with type 1 diabetes

X
Trial Profile

Paediatric onset study to assess the efficacy of insulin pump therapy using the MiniMed Paradigm REAL-Time system during the first year of diabetes in children and adolescents with type 1 diabetes

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 09 May 2013

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Insulin aspart (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms ONSET
  • Most Recent Events

    • 14 Aug 2010 Primary endpoint 'Proportion of glycosylated haemoglobin' has been met according to results published in Diabetologia.
    • 18 Oct 2009 Results have been presented at the 20th World Diabetes Congress (WDC).
    • 01 Sep 2009 Trial acronym (ONSET) identified as reported by ISRCTN: Current Controlled Trials record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top